News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valeant Pharmaceuticals International (VRX) to Partner with ASCEND Therapeutics, Inc. to Promote Migranal(R) to OB/GYNs


10/2/2007 11:01:51 AM

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE:VRX) today announced that it has granted ASCEND Therapeutics exclusive rights to deploy ASCEND’s 50-person specialty sales force to promote Valeant’s Migranal® (dihydroergotamine mesylate, USP) Nasal Spray to more than 5,500 OB/GYNs in the United States. Valeant will continue to market Migranal to physicians outside the OB/GYN specialty area and retain all other responsibilities for the product.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES